News

In this capacity Ms Baird will provide leadership and strategic direction in the areas of regulatory and quality affairs and in clinical operations. Most recently, Ms Baird was

“In his eight years at Novo Nordisk, Andy has developed an impressive track record for building high performing field sales teams,” said Jerzy Gruhn, president of Novo Nordisk

CE marking means conformity to the applicable European directive and in the specific context of diabetes, permits the Cypher Select Plus stent to be marketed for the treatment

The agreements concern both the distribution rights for MultiSynTech’s systems and the establishment of a joint development project. The agreements with MultiSynTech will grant Biotage distribution rights for

“Gen-Probe posted strong financial results in the fourth quarter of 2008, driven by healthy growth in both clinical diagnostics and blood screening sales,” said Hank Nordhoff, the company’s

The trial currently conducted in the UK is investigating the safety and efficacy of Sanofi Pasteur’s Clostridium difficile (CDI) candidate vaccine. While the target indication for the vaccine

The current Phase I trial is the first time CB-183,315 has been given to humans and is designed to evaluate the safety and pharmacokinetics of single escalating oral

Dr Nichols previously served as regional chairman, medical director, and director of hematopathology of the Bon Secours Richmond Regional Laboratory System, and is a past president of the

Under the companies’ collaboration agreement, Curis will receive a $6 million cash payment from Genentech following initiation of this pivotal trial. Genentech expects to evaluate GDC-0449 in approximately